A recurrent mutation in PARK2 is associated with familial lung cancer.

Xiong D, Wang Y, Kupert E, Simpson C, Pinney SM, Gaba CR, Mandal D, Schwartz AG, Yang P, de Andrade M, Pikielny C, Byun J, Li Y, Stambolian D, Spitz MR, Liu Y, Amos CI, Bailey-Wilson JE, Anderson M, You M. A recurrent mutation in PARK2 is associated with familial lung cancer. Am J Hum Genet. 2015 Feb 05; 96(2):301-8.

View in: PubMed

subject areas

Base Sequence
DNA Primers
Female
Genetic Predisposition to Disease
Germ-Line Mutation
Humans
Lung Neoplasms
Male
Molecular Sequence Data
Mutation, Missense
Odds Ratio
Pedigree
Sequence Analysis, DNA
Ubiquitin-Protein Ligases

authors with profiles

Anna Schwartz

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support